Related Experiment Video
Updated: May 4, 2026

In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity
Published on: January 29, 2018
SUMOylation inhibits FOXM1 activity and delays mitotic transition
S S Myatt1, M Kongsema1, C W-Y Man2
1Department of Surgery and Cancer, Imperial College London, Imperial Centre for Translational and Experimental Medicine (ICTEM), London, UK.
Abstract:
The forkhead box transcription factor FOXM1 is an essential effector of G2/M-phase transition, mitosis and the DNA damage response. As such, it is frequently deregulated during tumorigenesis. Here we report that FOXM1 is dynamically modified by SUMO1 but not by SUMO2/3 at multiple sites. We show that FOXM1 SUMOylation is enhanced in MCF-7 breast cancer cells in response to treatment with epirubicin and mitotic inhibitors. Mutation of five consensus conjugation motifs yielded a SUMOylation-deficient mutant FOXM1. Conversely, fusion of the E2 ligase Ubc9 to FOXM1 generated an auto-SUMOylating mutant (FOXM1-Ubc9). Analysis of wild-type FOXM1 and mutants revealed that SUMOylation inhibits FOXM1 activity, promotes translocation to the cytoplasm and enhances APC/Cdh1-mediated ubiquitination and degradation. Further, expression of the SUMOylation-deficient mutant enhanced cell proliferation compared with wild-type FOXM1, whereas the FOXM1-Ubc9 fusion protein resulted in persistent cyclin B1 expression and slowed the time from mitotic entry to exit. In summary, our findings suggest that SUMOylation attenuates FOXM1 activity and causes mitotic delay in cytotoxic drug response.
Insights
SUMOylation of FOXM1 (forkhead box transcription factor) inhibits its activity, promoting cell cycle arrest and degradation. This process is crucial for the cellular response to DNA damage and chemotherapy.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- FOXM1 (forkhead box transcription factor) is vital for cell cycle progression and DNA damage response.
- Dysregulation of FOXM1 is common in various cancers.
- Post-translational modifications, like SUMOylation, can regulate protein function.
Purpose of the Study:
- To investigate the role of SUMOylation in regulating FOXM1 activity and its impact on cell cycle control.
- To explore how SUMOylation affects FOXM1 localization, stability, and function in response to cellular stress.
Main Methods:
- SUMOylation assays using wild-type and mutant FOXM1 (SUMOylation-deficient and auto-SUMOylating FOXM1-Ubc9).
- Analysis of FOXM1 localization, ubiquitination, and degradation.
- Cell proliferation assays and cell cycle analysis (mitotic entry/exit).
- Treatment of MCF-7 breast cancer cells with epirubicin and mitotic inhibitors.
Main Results:
- FOXM1 undergoes dynamic SUMOylation, particularly in response to epirubicin and mitotic inhibitors.
- SUMOylation of FOXM1 inhibits its transcriptional activity, promotes cytoplasmic localization, and enhances its degradation via APC/Cdh1.
- A SUMOylation-deficient FOXM1 mutant increased cell proliferation.
- The FOXM1-Ubc9 fusion protein led to persistent cyclin B1 expression and delayed mitotic exit.
Conclusions:
- SUMOylation acts as a negative regulator of FOXM1 activity.
- SUMOylation-mediated regulation of FOXM1 is critical for mitotic delay and cellular response to cytotoxic drugs.
- Targeting FOXM1 SUMOylation could be a therapeutic strategy in cancer treatment.
Related Concept Videos
Abnormal Proliferation
Meiosis II
The timing and cell division patterns of meiosis differ between males and females. In male meiosis, the centrosomes are part of the formation of the meiotic spindle. However, in oocytes, including that of humans, Drosophila,...
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
Meiosis vs. Mitosis
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
MicroRNAs
MicroRNAs

